Literature DB >> 26872120

Clozapine Underutilization in the Treatment of Schizophrenia: How Can Clozapine Prescription Rates Be Improved?

Jan P A M Bogers1, Peter F J Schulte, Daniel Van Dijk, Bert Bakker, Dan Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26872120     DOI： 10.1097/JCP.0000000000000478

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  14 in total

Review 1.  Delayed Initiation of Clozapine Continues to Be a Substantial Clinical Concern.

Authors:  Alexander Panickacheril John; Elvin Kay Fon Ko; Arun Dominic
Journal:  Can J Psychiatry       Date:  2018-04-22       Impact factor: 4.356

Review 2.  Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis.

Authors:  Dan Siskind; Victor Siskind; Steve Kisely
Journal:  Can J Psychiatry       Date:  2017-06-28       Impact factor: 4.356

3.  There Is Life After the UK Clozapine Central Non-Rechallenge Database.

Authors:  Ebenezer Oloyede; Cecilia Casetta; Olubanke Dzahini; Aviv Segev; Fiona Gaughran; Sukhi Shergill; Alek Mijovic; Marinka Helthuis; Eromona Whiskey; James Hunter MacCabe; David Taylor
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

4.  Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study.

Authors:  Petru Ifteni; Andreea Teodorescu; Marius Alexandru Moga; Alina Mihaela Pascu; Roxana Steliana Miclaus
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-23       Impact factor: 2.570

5.  Prescription and Underprescription of Clozapine in Dutch Ambulatory Care.

Authors:  Yvonne C van der Zalm; Fabian Termorshuizen; Peter F Schulte; Jan P Bogers; Machteld Marcelis; Iris E Sommer; Jean Paul Selten
Journal:  Front Psychiatry       Date:  2018-06-11       Impact factor: 4.157

6.  Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.

Authors:  C Okhuijsen-Pfeifer; E A H Huijsman; A Hasan; I E C Sommer; S Leucht; R S Kahn; J J Luykx
Journal:  Acta Psychiatr Scand       Date:  2018-09-14       Impact factor: 6.392

Review 7.  Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.

Authors:  Sang Won Jeon; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2017-10-18       Impact factor: 5.923

Review 8.  A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.

Authors:  Jose de Leon; Can-Jun Ruan; Georgios Schoretsanitis; Carlos De Las Cuevas
Journal:  Psychother Psychosom       Date:  2020-04-14       Impact factor: 17.659

9.  Resolution without discontinuation: heart failure during clozapine treatment.

Authors:  Eromona Whiskey; Shirley Yuen; Emma Khosla; Susan Piper; David O'Flynn; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-04

10.  A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting.

Authors:  Thomas Maestri; David Anderson; Jose Calderon-Abbo; Taylor Waguespack; Margarita Echeverri
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.